CRH

Predictive Oncology Reports Year End 2023 Financial Results and Provides Business Update

Retrieved on: 
Thursday, March 28, 2024
Consultant, CRH, Ovarian cancer, Conference call, Conference, Survival, Science, Intelligence, Drug discovery, Webcast, BIO, Research, Holocene, UPMC, KOL, G&A, Call, GMP, UPMC Magee-Womens Hospital, Cloud computing, CLIA, Drug development, Machine learning, Marketing, Artificial intelligence, Cryptocurrency

The company reported a net loss of approximately $14 million on total revenue of approximately $1.8 million for the year ended December 31, 2023.

Key Points: 
  • The company reported a net loss of approximately $14 million on total revenue of approximately $1.8 million for the year ended December 31, 2023.
  • “Perhaps most notably, we announced last quarter that we successfully delivered the results of our first campaign with Cancer Research Horizons.
  • Revenues for the years ended December 31, 2023, and December 31, 2022, were primarily derived from its Eagan operating segment.
  • Conference call and webcast details:
    Predictive Oncology management will host an investor conference call and webcast on Monday, April 1st, at 8:30am EDT.

HEALWELL AI Announces New Commercial Agreements with WELL HEALTH USA and Circle Medical, Bringing AI-Based Preventative Care Solutions to U.S. Market

Retrieved on: 
Thursday, March 14, 2024
Diagnosis, CRH, Algorithm, Partnership, Risk, EMR, Patient, SAN, Artificial intelligence, AI, WELL, Inflammatory bowel disease, IBD, TSX, OTCQX, Clinical trial, Strategic alliance, AIDX, Medical device

HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions.

Key Points: 
  • HEALWELL AI has signed services agreements with both WELL Health USA and U.S. based Circle Medical Technologies Inc., which expands its footprint in the U.S. and will enable U.S. healthcare providers with a suite of artificial intelligence (AI) powered preventative care solutions.
  • HEALWELL’s Khure Health will integrate its proprietary AI platform with Circle Medical’s electronic medical record system, expanding its footprint to over 30 US states.
  • Enabling WELL USA and Circle Medical providers is a demonstration of this commitment and a major step forward for HEAWELL into the US market.
  • George Favvas, CEO of Circle Medical commented, “We are excited to partner with Khure and bring their AI solutions to the healthcare practitioners we support.

CRH Acquires California-Based Companies BoDean and Northgate Ready Mix

Retrieved on: 
Friday, April 5, 2024
Engineering, Other Construction & Property, Manufacturing, Commercial Building & Real Estate, Construction & Property, Building Systems, Other Manufacturing, CRH, Acquisition, Plant, Growth, Record

CRH today announced the acquisition of BoDean Company Inc. and Northgate Ready Mix, LLC in Santa Rosa, CA.

Key Points: 
  • CRH today announced the acquisition of BoDean Company Inc. and Northgate Ready Mix, LLC in Santa Rosa, CA.
  • Both companies complement CRH’s Materials Solutions business in the Western U.S. and add two aggregates quarries, two ready mixed concrete plants, one asphalt plant and one recycle plant to its operations.
  • BoDean and Northgate have proven track records for supplying customers with quality materials and are also known for innovation and sustainability.
  • “We are delighted to welcome all BoDean and Northgate employees to the CRH family,” said Scott Parson, President, Americas Materials Solutions, CRH.

Global Recycled Concrete Industry Research 2024: Market Trends with Data from 2022, Estimates for 2023, and CAGR Projections Through 2028 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, April 3, 2024
Residential Building & Real Estate, Commercial Building & Real Estate, Urban Planning, Manufacturing, Construction & Property, Landscape, Building Systems, Architecture, Other Manufacturing, Engineering, Other Construction & Property, CRH, Construction, Environment, ESG, CEMEX, USD, CRH plc, Recycling

The Global Recycled Concrete Market was valued at USD 11.1 Billion in 2023, and is expected to reach USD 17.40 Billion by 2028, rising at a CAGR of 9.30%.

Key Points: 
  • The Global Recycled Concrete Market was valued at USD 11.1 Billion in 2023, and is expected to reach USD 17.40 Billion by 2028, rising at a CAGR of 9.30%.
  • The report discusses different product types and end uses of recycled concrete in residential and non-residential industries across the regions.
  • It offers a detailed analysis of various product types and the prevalent trends and opportunities in the market.
  • The major companies in the global market for recycled concrete are Arcosa Inc., CRH Plc., CEMEX S.A.B.

CRH completes second phase of European lime divestment

Retrieved on: 
Wednesday, March 27, 2024
Mining, Minerals, Other Construction & Property, Manufacturing, Natural Resources, Construction & Property, Building Systems, Other Manufacturing, CRH plc, CRH

On 22 November 2023, CRH plc announced that it had reached an agreement to divest its lime operations in Europe for a total consideration of c.$1.1 billion. CRH is pleased to announce that the second phase of the transaction, comprising the Group’s lime operations in the UK, is now complete.

Key Points: 

On 22 November 2023, CRH plc announced that it had reached an agreement to divest its lime operations in Europe for a total consideration of c.$1.1 billion. CRH is pleased to announce that the second phase of the transaction, comprising the Group’s lime operations in the UK, is now complete.

Edgewood Oncology Emerges From Stealth with $20 Million in Series A Financing to Advance BTX-A51 in Patients with Hematologic Malignancies and Genetically-Defined Solid Tumors

Retrieved on: 
Monday, March 25, 2024
Science, Biotechnology, Research, Oncology, General Health, Health, Genetics, Clinical Trials, Toxicity, CDK7, Apoptosis, Hebrew University of Jerusalem, CRH, CRi, AML, Patient, Immunology, Acute myeloid leukemia, Cancer, Medicine, Alta Partners, Therapy, Drug development, Breast cancer, Safety, Azacitidine, Pharmacokinetics, CDK9, Bone marrow, Pharmaceutical industry

Edgewood acquired the rights to BTX-A51 from Yissum, the technology transfer company of The Hebrew University of Jerusalem, in 2023 and will use the Series A funding to advance efficacy studies in AML and breast cancer.

Key Points: 
  • Edgewood acquired the rights to BTX-A51 from Yissum, the technology transfer company of The Hebrew University of Jerusalem, in 2023 and will use the Series A funding to advance efficacy studies in AML and breast cancer.
  • “We formed Edgewood Oncology because of the synergistic mechanism of action and promising safety and anti-tumor data that was observed with BTX-A51 in Phase 1 in AML and solid tumor patients.
  • In a Phase 1 study in heavily pre-treated R/R AML patients, monotherapy BTX-A51 demonstrated a favorable safety profile and encouraging antileukemic activity.
  • As a next step, Edgewood initiated a study of BTX-A51 in combination with azacitidine in R/R AML patients in December 2023.

Rigel Announces Publication of Data on REZLIDHIA® (Olutasidenib) in Post-Venetoclax Patients with Mutant IDH1 AML in Leukemia & Lymphoma

Retrieved on: 
Thursday, April 4, 2024
Platelet transfusion, CRi, CRC, Patient, Rigel, SAN, CRH, AML, Pharmaceutical industry

"Venetoclax in combination with a hypomethylating agent is currently standard treatment for patients with newly diagnosed AML who are unfit for intensive chemotherapy, including those with mIDH1.

Key Points: 
  • "Venetoclax in combination with a hypomethylating agent is currently standard treatment for patients with newly diagnosed AML who are unfit for intensive chemotherapy, including those with mIDH1.
  • "The findings from these analyses suggest that REZLIDHIA may provide an effective treatment for patients with AML following failure of venetoclax combination therapy.
  • "These data support REZLIDHIA's efficacy and well-characterized safety profile in patients with mIDH1 R/R AML who had previously been treated with venetoclax combination regimens," said Raul Rodriguez, Rigel's president and CEO.
  • Both patients with CRi at study entry achieved CR
    Median time to CRc was 1.9 months (range 1-2.8).

CRH Continues Share Buyback Program

Retrieved on: 
Thursday, February 29, 2024
Other Construction & Property, Commercial Building & Real Estate, Urban Planning, Construction & Property, CRH plc, Buyback, Share repurchase, Legislation, Barclays, CRH

CRH plc, the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders.

Key Points: 
  • CRH plc, the leading provider of building materials solutions, is pleased to announce that it has completed the latest phase of its share buyback program, returning a further $0.3 billion of cash to shareholders.
  • This brings total cash returned to shareholders under our ongoing share buyback program to $7.3 billion since its commencement in May 2018.
  • Barclays will conduct the Buyback on CRH’s behalf and will make trading decisions under the Buyback independently of CRH in accordance with certain pre-set parameters.
  • The purpose of the Buyback is to reduce the share capital of CRH.

CRH enters binding agreement to acquire Adbri in Australia

Retrieved on: 
Monday, February 26, 2024
Home Goods, Residential Building & Real Estate, Chemicals, Plastics, Retail, Commercial Building & Real Estate, Construction & Property, Manufacturing, Finance, Professional Services, Forest Products, Natural Resources, Urban Planning, Steel, Architecture, Other Construction & Property, Acquisition, Growth, CRH plc, Scheme, CRH, Partner, Partnership

On December 17, 2023, CRH plc, the leading provider of building materials solutions, together with the Barro Group (“Barro” and together with CRH the “Partners”), entered into an agreement with Adbri Ltd (“Adbri”) in relation to a potential transaction to acquire Adbri (the “Offer”) by way of a Scheme of Arrangement (“Scheme”).

Key Points: 
  • On December 17, 2023, CRH plc, the leading provider of building materials solutions, together with the Barro Group (“Barro” and together with CRH the “Partners”), entered into an agreement with Adbri Ltd (“Adbri”) in relation to a potential transaction to acquire Adbri (the “Offer”) by way of a Scheme of Arrangement (“Scheme”).
  • Following due diligence over the past two months, we are pleased to announce CRH and Adbri have entered into a binding agreement under which CRH will acquire the remaining 57% of the ordinary shares of Adbri not owned by Barro for the previously agreed cash consideration of A$3.20 per share.
  • Albert Manifold, Chief Executive of CRH, said: “We are pleased to reach this important milestone in the potential acquisition of Adbri in partnership with the Barro family.
  • We look forward to working with the Barro family over the coming years to enhance the long-term growth and performance of Adbri.”

Wellness Within Your Walls® Will Speak, Launch New Certification Program and Initiatives During Design & Construction Week at IBS and KIBS Feb. 27 -29, 2024 in Las Vegas

Retrieved on: 
Thursday, February 22, 2024
Steps, Expo, WWYW, Beer, Education, Bath, Construction, PBP, Holism, NAHB, Learning, Walking, Health, HLS, Cons, KBIS, Electrification, Science, NKBA, CRH, Healthy Living, IBS, Interior design

ATLANTA, Feb. 22, 2024 /PRNewswire-PRWeb/ -- Wellness Within Your Walls®(WWYW), an informational resource group which certifies people, places, products and programs to promote healthy living environments, will attend Design & Construction Week beginning Feb. 27 in Las Vegas and make several announcements at the conference. WWYW has certified industrial professionals and residences in 35 states and five countries and is a past winner of the Global Innovation Award from NAHB's Global Opportunities Board.

Key Points: 
  • WWYW's new PBP provides volume builders with a streamlined process to incorporate a nationwide standard for healthier homes for today's health-conscious home buyers.
  • WWYW will also offer the WWYW Healthy Home Toolkit™ for new home buyers to certifying builders.
  • IBS and KBIS are the ideal venues to do just that, so our team will be out in full force in Las Vegas."
  • A team of WWYW experts will traverse the IBS and KBIS conference floors, spotting new and innovative products, systems and technologies for healthier homes.